title: Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction.
abstract: Liver-directed gene transfer is being investigated for the treatment of systemic or liver-specific diseases. Recombinant vectors based on adeno-associated virus serotype 8 (AAV2/8) efficiently transduce liver cells allowing long term transgene expression after a single administration in animal models and in patients.We evaluated the impact on AAV2/8-mediated rat liver transduction of the following variables: i) age at vector administration, ii) presence of lysosomal storage in liver cells, and iii) regulatory elements included in the transgene expression cassette. We found that systemic administration of AAV2/8 to newborn rats results in vector genome dilution and reduced transduction efficacy when compared to adult injected animals, presumably due to hepatocyte proliferation. Accumulation of glycosaminoglycans in lysosomes does not impact on levels and distribution of AAV2/8-mediated liver transduction. Transgene expression occurs in hepatocytes but not in Kupffer or liver endothelial cells when the liver-specific thyroxine-binding-globulin promoter is used. However, extra-hepatic transduction is observed in the spleen and kidney of animals injected at birth. The use of target sequences for the hematopoietic-specific microRNA miR142-3p does not improve liver transduction efficacy neither reduce immune responses to the lysosomal enzyme arylsulfatase B. The inclusion of a variant of the Woodchuck hepatitis virus post-transcriptional regulatory element (WPRE-m) decreases AAV2/8-mediated liver transduction levels.As AAV2/8-mediated liver gene transfer is entering in the clinical arena, these data will provide relevant information to the design of efficient AAV2/8-based therapeutic strategies.
authors.affiliation: Telethon Institute of Genetics and Medicine, Naples, Italy.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Cotugno
authors.forename: Patrizia
authors.initials: P
authors.lastname: Annunziata
authors.forename: Maria Vittoria
authors.initials: MV
authors.lastname: Barone
authors.forename: Marianthi
authors.initials: M
authors.lastname: Karali
authors.forename: Sandro
authors.initials: S
authors.lastname: Banfi
authors.forename: Alberto
authors.initials: A
authors.lastname: Auricchio
mesh_terms: D000367:Age Factors; D000818:Animals; D015153:Blotting, Western; D004274:DNA, Recombinant / Q000235:genetics; D000229:Dependovirus; D004797:Enzyme-Linked Immunosorbent Assay; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics; D006025:Glycosaminoglycans / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000378:metabolism; D008107:Liver Diseases / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D008247:Lysosomes / Q000378:metabolism; D009841:Oligonucleotides / Q000235:genetics; D051381:Rats; D050436:Regulatory Elements, Transcriptional / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014161:Transduction, Genetic / Q000379:methods*; D019076:Transgenes / Q000235:genetics* / Q000502:physiology
chemical_list: D004274:DNA, Recombinant; D006025:Glycosaminoglycans; D009841:Oligonucleotides; D049452:Green Fluorescent Proteins